Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction have?
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction has 40 citations in the OpenAlex counts ScholarIQ stores.
When was Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction published?
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction has 2021 year in the ScholarIQ index.
What is the open-access status of Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction?
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction has closed oa status in the ScholarIQ index.
What is the DOI of Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction?
The DOI for Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction is on the source record.
What is the PMID of Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction?
The PMID for Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction is on the source record.
What is the OpenAlex record for Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction?
The OpenAlex for Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction is on the source record.